| Name | Presentation |
| Zachary Danaceau | Investigating the Role of ZattBP1 in TOP2-DPC Repair |
| Autumn Hughes | Renovascular Disease Alters the mRNA Cargo of Human Adipose-Derived Mesenchymal Stem Cells |
| Maureen Pelissero | A Comparative Study of Elastography Modalities to Quantify Wave Velocities in Ex Vivo Porcine Kidneys |
| Neha Rajan | Human-In-The-Loop Deep Learning Model for Quality Assessment of Kidney Endoscopy Frames |
| Una Stevic | Mesenchymal Stem Cell Paracrine-Mediated Repair in Diabetic Kidney Disease |
| Ethan Subel | Immune Cell Phenotyping Reveals Regulatory B Cells as Functional Biomarkers of IgA Nephropathy |
Teaching Competencies: Medical Knowledge
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Integrate recent developments in Nephrology and Hypertension to their current practice.
- Summarize rationale for drug treatment choices based on advances in clinical trials.
- Review basic mechanisms of disease and determine potential treatment target.
- Debate with colleagues best practices and current standard of care.
- Compare and critique various diagnostic as well as treatment strategies in Nephrology and Hypertension.
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Facebook
X
LinkedIn
Forward